Amalio Telenti
- Infectious Diseases top 0.01%
- Epidemiology top 0.05%
- Virology top 0.02%
- Molecular Biology top 1%
- Immunology top 0.5%
- Co-authors
- Thomas BodmerHansjakob FurrerLaurent A. DécosterdThierry BuclinFederica MarchesiJérôme BiollazPietro VernazzaCatia Marzolini
- Topics
- HIV Research and Treatment (161 papers)HIV/AIDS drug development and treatment (133 papers)HIV/AIDS Research and Interventions (66 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Amalio Telenti
352 papers receiving 26.2k citations
Hit Papers
Peers
Comparison fields: 5 of 201
- Infectious Diseases 15.3k
- Epidemiology 9.3k
- Virology 8.7k
- Molecular Biology 5.8k
- Immunology 3.0k
Countries citing papers authored by Amalio Telenti
This map shows the geographic impact of Amalio Telenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amalio Telenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amalio Telenti more than expected).
Fields of papers citing papers by Amalio Telenti
This network shows the impact of papers produced by Amalio Telenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amalio Telenti. The network helps show where Amalio Telenti may publish in the future.
Co-authorship network of co-authors of Amalio Telenti
This figure shows the co-authorship network connecting the top 25 collaborators of Amalio Telenti. A scholar is included among the top collaborators of Amalio Telenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amalio Telenti. Amalio Telenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 99 | |
| 2 | 8 | |
| 3 | 52 | |
| 4 | 20 | |
| 5 | 44 | |
| 6 | 203 | |
| 7 | 195 | |
| 8 | 32 | |
| 9 | 23 | |
| 10 | 41 | |
| 11 | 7 | |
| 12 | 2 | |
| 13 | 17 | |
| 14 | 40 | |
| 15 | 21 | |
| 16 | 95 | |
| 17 | 5 | |
| 18 | Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued ? | 38 |
| 19 | Heterogeneity in the response to antiretroviral therapy. | 4 |
| 20 | [Giant-cell arteritis of temporal localization and hepatic granulomatosis]. | 1 |
About Amalio Telenti
Amalio Telenti is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 355 papers that have together received 27.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (161 papers), HIV/AIDS drug development and treatment (133 papers) and HIV/AIDS Research and Interventions (66 papers). The work is most often cited by research in Virology (8.7k citations), Infectious Diseases (15.3k citations) and Emergency Medicine (2.7k citations). Amalio Telenti has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Thomas Bodmer, Hansjakob Furrer, Laurent A. Décosterd, Thierry Buclin, Federica Marchesi, Jérôme Biollaz, Pietro Vernazza, Catia Marzolini, P Francioli and Bernard Hirschel. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.